Hepatocellular carcinoma (HCC) exhibiting low expression of FBP1 had a highly malignant phenotype, including large tumour size, poor differentiation, and advanced tumour stage [15, 80–82], as well as vascular cell invasion and a high pathological grade (stages III–IV) [14]. This evidence concerns the gene FBP1 and hepatocellular carcinoma.